29 Paul Tudor Jones II Labcorp Holdings Trades
The first Labcorp Holdings trade was made in Q4 2013. Since then Paul Tudor Jones II bought shares seventeen more times and sold shares on 23 occasions. The investor completely sold their stake between Q1 2023 and Q2 2023.
News about Labcorp Holdings Inc. and Paul Tudor Jones II
UCM Technologies Inc. Presented a Revolutionary Three-Biomarker Signature Test for Early Stage (Stages I-II) Detection of Non-Small Cell Lung Cancer at the American Society of Clinical Oncology (ASCO) 2023 Meeting in Chicago IL
CHICAGO, IL / ACCESSWIRE / June 4, 2023 / UCM Technologies has utilized a breakthrough combination of biomarkers (CA-62, CEA and CYFRA 21-1) to detect lung c...
Clinical Trials Market Worth $52.0 Billion, Global Update, Share Analysis, Leading Players, Business Opportunities, Forecast by 2026
In September 2021, Syneos Health entered into a strategic collaboration with Ride Health to offer non-emergency medical transportation (NEMT) for clinical tr...
Integral Health Asset Management, LLC Buys Anthem Inc, Biogen Inc, Regeneron Pharmaceuticals ...
Related Stocks: ANTM , SAGE , ZNTL , GMED , MDT , FATE , BIIB , REGN , UHS , SNY , ABC , EW , NTLA , NVST , DHR , ACHC , ZBH , BCRX , CRL , MCK , CNC , MRK ,...
The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 4) Abbott Labo...